Successful treatment of alopecia areata with topical calcipotriol

Annals of Dermatology

Volumn 24, Issue 3, 2012, Pages 341-344

  Kim, Dong Ha ^a   Lee, Jin Woong ^a   Kim, In Su ^a   Choi, Sun Young ^a   Lim, Yun Young ^a   Kim, Hyeong Mi ^a   Kim, Beom Joon ^a   Kim, Myeung Nam ^a  

^a Chung Ang University   (South Korea)

Author keywords

Alopecia areata; Calcipotriol; Therapeutics; Vitamin D

Indexed keywords

EID: 84864360693     PISSN: 10139087     EISSN: None     Source Type: Journal    
DOI: 10.5021/ad.2012.24.3.341     Document Type: Article

References (16)

1. Reichrath J, Schilli M, Kerber A, Bahmer FA, Czarnetzki BM, Paus R. Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle. Br J Dermatol 1994;131:477-482. (Pubitemid 24315414)
2. Reichel H, Koeffler HP, Norman AW. The role of the vitamin D endocrine system in health and disease. N Engl J Med 1989;320:980-991. (Pubitemid 19101616)
3. Xie Z, Komuves L, Yu QC, Elalieh H, Ng DC, Leary C, et al. Lack of the vitamin D receptor is associated with reduced epidermal differentiation and hair follicle growth. J Invest Dermatol 2002;118:11-16. (Pubitemid 34107418)
4. Sakai Y, Kishimoto J, Demay MB. Metabolic and cellular analysis of alopecia in vitamin D receptor knockout mice. J Clin Invest 2001;107:961-966. (Pubitemid 32323406)
5. Forghani N, Lum C, Krishnan S, Wang J, Wilson DM, Blackett PR, et al. Two new unrelated cases of hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia resulting from the same novel nonsense mutation in the vitamin D receptor gene. J Pediatr Endocrinol Metab 2010; 23:843-850.
6. MacDonald Hull SP, Wood ML, Hutchinson PE, Sladden M, Messenger AG; British Association of Dermatologists. Guidelines for the management of alopecia areata. Br J Dermatol 2003;149:692-699. (Pubitemid 37419985)
7. Nancy AL, Yehuda S. Prediction and prevention of auto immune skin disorders. Arch Dermatol Res 2009;301:57-64.
8. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: Part II. Treatment. J Am Acad Dermatol 2010;62:191-202.
9. Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: New aetiological and therapeutic considerations. Ann Rheum Dis 2007;66:1137-1142. (Pubitemid 47309727)
10. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001;167:4974-4980. (Pubitemid 33009728)
11. van Etten E, Mathieu C. Immunoregulation by 1,25- dihydroxyvitamin D3: Basic concepts. J Steroid Biochem Mol Biol 2005;97:93-101. (Pubitemid 41546218)
12. Linker-Israeli M, Elstner E, Klinenberg JR, Wallace DJ, Koeffler HP. Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. Clin Immunol 2001;99:82-93.
13. Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A 2001;98:6800-6805. (Pubitemid 32538297)
14. D'Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 1998;101:252-262. (Pubitemid 28058925)
15. Segaert S, Simonart T. The epidermal vitamin D system and innate immunity: Some more light shed on this unique photoendocrine system? Dermatology 2008;217:7-11. (Pubitemid 351896560)
16. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001;86:888-894. (Pubitemid 32207511)